Cells of the innate system respond rapidly to molecular patterns shared by a broad array of pathogens. Meanwhile, the adaptive system, consisting of T and B cells, responds more slowly, targeting ...

A team has succeeded in identifying a specific marker on the surface of tumour cells, and in generating immune cells carrying an antibody to destroy them. Furthermore, these cells, called CAR-T ...

Here authors show that by looking at epigenetic markers in human CD8 + T cells and CAR-T cells, properties and quality of these cells, which are not obvious from gene expression analysis ...

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases ...

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue. Glioblastoma is the most common and most aggressive primary brain ...

The U.K.'s Black History Month presents an opportunity for sickle cell patients to combat false narratives, columnist Mary ...

We appreciate that the ink is low odor, so we don’t have to worry about any unpleasant smells in our workspace. Overall, the Amazon Basics Low-Odor Chisel Tip Dry Erase White Board Marker ...

Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of ...

Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In ...

"One of these markers, PTPRZ1, proved particularly important: we were able to generate CAR-T cells carrying antibodies targeting PTPRZ1. This is a first step towards CAR-T cells effective against ...